biblio

Filters: Author is Shastri, Nalini R.  [Clear All Filters]
2016
R. Thipparaboina, Mittapalli, S., Thatikonda, S., Nangia, A., Naidu, V. G. M., and Shastri, N. R., “Syringic acid: structural elucidation and co-crystallization”, Crystal Growth & Design, vol. 16, no. 8, pp. 4679-4687, 2016.
2018
N. Salunke, Thipparaboina, R., Chavan, R. B., Lodagekar, A., Mittapalli, S., Nangia, A., and Shastri, N. R., “Rufinamide: crystal structure elucidation and solid state characterization”, Journal of Pharmaceutical and Biomedical Analysis, vol. 149, pp. 185-192, 2018.
2019
A. Lodagekar, Chavan, R. B., Mannava, M. K. Chaitan, Yadav, B., Chella, N., Nangia, A. K., and Shastri, N. R., “Co amorphous valsartan nifedipine system: Preparation, characterization, in vitro and in vivo evaluation”, European Journal of Pharmaceutical Sciences, vol. 139, 2019.
B. Yadav, Gunnam, A., Thipparaboina, R., Nangia, A. K., and Shastri, N. R., “Hepatoprotective cocrystals of isoniazid: synthesis, solid state characterization, and hepatotoxicity studies”, Crystal Growth & Design, vol. 19, no. 09, pp. 5161-5172, 2019.
V. Bhavana, Chavan, R. B., Mannava, M. K. Chaitan, Nangia, A., and Shastri, N. R., “Quantification of niclosamide polymorphic forms - a comparative study by Raman, NIR and MIR using chemometric techniques”, Talanta, vol. 199, pp. 679-688, 2019.
2020
S. Modani, Gunnam, A., Yadav, B., Nangia, A. K., and Shastri, N. R., “Generation and evaluation of pharmacologically relevant drug-drug cocrystal for gout therapy”, Crystal Growth & Design, vol. 20, no. 6, pp. 3577-3583, 2020.
2021
M. K. Chaitan Mannava, Gunnam, A., Lodagekar, A., Shastri, N. R., Nangia, A. K., and K. Solomon, A., “Enhanced solubility, permeability, and tabletability of nicorandil by salt and cocrystal formation”, Crystengcomm, vol. 23, no. 1, pp. 227-237, 2021.
2022
D. Tomar, Lodagekar, A., Gunnam, A., Allu, S., Chavan, R. B., Tharkar, M., Ajithkumar, T. G., Nangia, A. K., and Shastri, N. R., “The effects of cis and trans butenedioic acid on the physicochemical behavior of lumefantrine”, Crystengcomm, vol. 24, no. 1, pp. 156-168, 2022.